Research every candidate against your criteria.

Research drugs, companies, and trials against consistent criteria, with evidence and open questions beside each answer.

Your research columnWhere is the evidence limited?

Candidate	Clinical benefit	Evidence limits
Dupilumab	Exacerbations + lung function
Mepolizumab	Exacerbations

Select an answer to inspect the evidence.

Evidence summary

No significant between-group difference in quality of life or symptoms.

Turn your next screening question into a research column.

Add a column for clinical differentiation, evidence gaps, or fit with your target product profile.

Define the candidate set: Filter by indication, mechanism, stage, and other structured fields before adding your research columns.
Inspect the reasoning: Open a cell to review supporting quotes, evidence ratings, and research steps.

Your next research column

Our criterion: reduce exacerbations, with quality-of-life differentiation assessed separately.

Maven researches each row

Mepolizumab · Example team assessment

The exacerbation result addresses our stated criterion. MATINEE did not establish a quality-of-life or symptom benefit.

“Between-group differences in measures of health-related quality of life and symptoms were not significant”

Smart TableCOPD · Competitive assessment

Compare dupilumab and mepolizumab. Where does the clinical evidence support differentiation?

Scroll across to compare all columns →

Drug & mechanism	Which outcomes improved?	Where is the evidence limited?	What should we investigate next?
DupilumabIL-4Rα antibody	Fewer exacerbations and better lung function. BOREAS NOTUS	Quality-of-life results differ between the two trials.Trial-specific findings	How consistent is the benefit across endpoints and patient groups?Compare the primary publications
MepolizumabIL-5 antibody	Fewer exacerbations and a longer time to the first event. MATINEE	No significant quality-of-life or symptom benefit.Direct evidence · MATINEE	Does an exacerbation benefit address the team’s target product profile?Apply your assessment criteria

Give the Research Agent the candidate and follow-up questions for a deeper assessment.

Extract the same details across publications, abstracts, or diligence documents in a Document Grid.

Build a sourced report with the rationale for each candidate and the questions still open.